As discussed in Section 5, the 90% clearance rate of liver fat makes Retatrutide a potential first-line therapy for those at risk of liver fibrosis or cirrhosis, even if their primary goal isn't just aesthetic weight loss
Some insurance companies and employers have been hesitant to cover the treatments due to their high cost
This story is by Madeleine Kates and was originally published in the spring 2025 issue of University of Pennsylvania School of Nursing Magazine.
Mariana Herrera Jen Hill assisted me with my case at A&W
GLP-1 has become a buzzed-about hormone thanks to the rise of popular weight-management medications, but your body already makes its own versionand how well it works can influence appetite, fullness, blood sugar, and even cravings
Morgan Stanley is already predicting that GLP-1s will cause a drop in sales for alcohol businesses